2
Clinical Trials associated with Cancer Vaccine (Maxhealth Biotechnology)Phase 1/2 Clinical Study of S-488410 Multipeptide Cancer Vaccine in Patients with Advanced or Recurrent Esophageal Squamous Cell Carcinoma - Phase 1/2 Clinical Study of S-488410 in Patients with Advanced or Recurrent Esophageal Squamous Cell Carcinoma
CHP-MAGE-A4 cancer vaccine study for refractory MAGE-A4-expressing cancer - CHP-MAGE-A4 cancer vaccine study
Start Date01 Jul 2009 |
Sponsor / Collaborator- |
100 Clinical Results associated with Cancer Vaccine (Maxhealth Biotechnology)
100 Translational Medicine associated with Cancer Vaccine (Maxhealth Biotechnology)
100 Patents (Medical) associated with Cancer Vaccine (Maxhealth Biotechnology)
100 Deals associated with Cancer Vaccine (Maxhealth Biotechnology)